Company Description
Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States.
Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk.
The company's products are used in military and police, and defense applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry.
Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation.
Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
Country | MI |
Founded | 2006 |
Industry | Specialty Chemicals |
Sector | Materials |
Employees | 37 |
CEO | Kim Kraig Thompson |
Contact Details
Address: 2723 South State Street, Suite 150 Ann Arbor, Michigan 48104 United States | |
Phone | (734) 619-8066 |
Website | kraiglabs.com |
Stock Details
Ticker Symbol | KBLB |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001413119 |
CUSIP Number | 50075W104 |
ISIN Number | US50075W1045 |
Employer ID | 83-0459707 |
SIC Code | 2820 |
Key Executives
Name | Position |
---|---|
Kim Kraig Thompson | Founder, Chairman, Chief Executive Officer, President, Chief Financial Officer and Corporate Secretary |
Jonathan R. Rice | Chief Operating Officer |
Kenneth Le | Director of Government Relations and President of Prodigy Textiles |
Dr. Trevor L. Kane | Chief Scientist and Member of Scientific Advisory Board |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 14, 2024 | 10-Q | Quarterly Report |
Apr 1, 2024 | 10-K | Annual Report |
Apr 1, 2024 | 8-K | Current Report |
Nov 22, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Nov 16, 2023 | 424B3 | Prospectus |
Nov 13, 2023 | 10-Q | Quarterly Report |
Sep 11, 2023 | 424B3 | Prospectus |
Sep 7, 2023 | EFFECT | Notice of Effectiveness |
Sep 1, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Sep 1, 2023 | POS AM | Post-Effective amendments for registration statement |